112 related articles for article (PubMed ID: 27150393)
1. Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans.
Xiao C; Dash S; Morgantini C; Lewis GF
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1457-63. PubMed ID: 27150393
[TBL] [Abstract][Full Text] [Related]
2. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men.
Xiao C; Dash S; Stahel P; Lewis GF
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575
[TBL] [Abstract][Full Text] [Related]
3. Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans.
Xiao C; Dash S; Morgantini C; Lewis GF
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1056-62. PubMed ID: 23471231
[TBL] [Abstract][Full Text] [Related]
4. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
Nogueira JP; Maraninchi M; Béliard S; Padilla N; Duvillard L; Mancini J; Nicolay A; Xiao C; Vialettes B; Lewis GF; Valéro R
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
[TBL] [Abstract][Full Text] [Related]
5. Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans.
Xiao C; Bandsma RH; Dash S; Szeto L; Lewis GF
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1513-9. PubMed ID: 22492091
[TBL] [Abstract][Full Text] [Related]
6. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
[TBL] [Abstract][Full Text] [Related]
7. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
Dash S; Xiao C; Morgantini C; Szeto L; Lewis GF
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2895-901. PubMed ID: 24072699
[TBL] [Abstract][Full Text] [Related]
8. Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.
Duez H; Lamarche B; Valéro R; Pavlic M; Proctor S; Xiao C; Szeto L; Patterson BW; Lewis GF
Circulation; 2008 May; 117(18):2369-76. PubMed ID: 18443237
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-2 regulates release of chylomicrons from the intestine.
Dash S; Xiao C; Morgantini C; Connelly PW; Patterson BW; Lewis GF
Gastroenterology; 2014 Dec; 147(6):1275-1284.e4. PubMed ID: 25173752
[TBL] [Abstract][Full Text] [Related]
10. Dietary medium-chain triglyceride supplementation has no effect on apolipoprotein B-48 and apolipoprotein B-100 kinetics in insulin-resistant men.
Tremblay AJ; Lamarche B; Labonté MÈ; Lépine MC; Lemelin V; Couture P
Am J Clin Nutr; 2014 Jan; 99(1):54-61. PubMed ID: 24172309
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans.
Xiao C; Pavlic M; Szeto L; Patterson BW; Lewis GF
Diabetes; 2011 Feb; 60(2):383-90. PubMed ID: 20980459
[TBL] [Abstract][Full Text] [Related]
12. New and emerging regulators of intestinal lipoprotein secretion.
Xiao C; Dash S; Morgantini C; Lewis GF
Atherosclerosis; 2014 Apr; 233(2):608-615. PubMed ID: 24534456
[TBL] [Abstract][Full Text] [Related]
13. Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids.
Pavlic M; Xiao C; Szeto L; Patterson BW; Lewis GF
Diabetes; 2010 Mar; 59(3):580-7. PubMed ID: 20028946
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.
Qin B; Qiu W; Avramoglu RK; Adeli K
Diabetes; 2007 Feb; 56(2):450-61. PubMed ID: 17259391
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia-induced hyperinsulinemia acutely lowers plasma apolipoprotein B but not lipoprotein (a) in man.
Riemens SC; Ligtenberg JJ; Dullaart RP
Clin Chim Acta; 1997 May; 261(2):149-58. PubMed ID: 9201434
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
Duez H; Lamarche B; Uffelman KD; Valero R; Cohn JS; Lewis GF
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
[TBL] [Abstract][Full Text] [Related]
18. Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ
Chétiveaux M; Croyal M; Ouguerram K; Fall F; Flet L; Zair Y; Nobecourt E; Krempf M
Sci Rep; 2020 Sep; 10(1):15585. PubMed ID: 32973209
[TBL] [Abstract][Full Text] [Related]
19. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction.
Haidari M; Leung N; Mahbub F; Uffelman KD; Kohen-Avramoglu R; Lewis GF; Adeli K
J Biol Chem; 2002 Aug; 277(35):31646-55. PubMed ID: 12070142
[TBL] [Abstract][Full Text] [Related]
20. Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance.
Drouin-Chartier JP; Tremblay AJ; Hogue JC; Lemelin V; Lamarche B; Couture P
J Lipid Res; 2018 Aug; 59(8):1501-1509. PubMed ID: 29946054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
